At a Glance
| 2-Aminoindane | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–20 mg | 4–6 mg |
| Total Duration | 0.5–1.5 hrs | 3.1–11 hrs |
| Routes | oral | oral |
| Effects | 27 documented | 44 documented |
2-Aminoindane, a Stimulants, and 3,4-CTMP, a Stimulants, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Stimulantss, meaning they share a common pharmacological foundation. They share 21 documented effects in common, with 6 effects unique to 2-Aminoindane and 23 unique to 3,4-CTMP. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 2-Aminoindane | 3,4-CTMP | |
|---|---|---|
| Class | Stimulants | Stimulants |
| Common Dose (oral) | 10–20 mg | 4–6 mg |
| Total Duration | 0.5–1.5 hrs | 3.1–11 hrs |
| Routes | oral | oral |
| Effects | 27 documented | 44 documented |
| Level | 2-Aminoindane | 3,4-CTMP |
|---|---|---|
| Threshold | 3 mg | 2 mg |
| Light | 5–10 mg | 2–4 mg |
| Common | 10–20 mg | 4–6 mg |
| Strong | 20–40 mg | 6–8 mg |
| Heavy | 40 mg | 8 mg |
2-Aminoindane
3,4-CTMP
No direct interaction data available between these substances. This does not mean the combination is safe.